search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


14 resulaten gevonden voor Allogeneic stem cell transplantation in trials

A phase II trial in patients with myelofibrosis (primary, post-ET or post PV-MF) treated with the selective JAK2 inhibitor Pacritinib before reduced-intensity conditioning allogeneic stem cell transplantation
- TRIAL ID
NTR6751
- ACRONYMHOVON 134 MF
Feasibility 'innate' allogeneic stem cells transplantion
- TRIAL ID
NTR5013
- ACRONYM
TRough vs AUC Monitoring of cyclosporine: A randomized comparison of adverse drug reactions in allogeneic stem cell recipients
- TRIAL ID
NTR4996
- ACRONYMTRAM study
Transfer of multiantigen-specific T cells after allogeneic stem cell transplantation
- TRIAL ID
NTR4801
- ACRONYMT control
Natural killer cell infusion after stem cell transplantation for leukemia
- TRIAL ID
NTR4403
- ACRONYMIL-15 activated NK cells
FLAMSA chemotherapy directly followed by donor stem cell transplantation in elderly patients with acute myeloid leukemia (AML) or high risk myelodysplasia (MDS)
- TRIAL ID
NTR4014
- ACRONYMFLAMSA TCD NMA AlloSCT
Treatment guided by detection of Minimal Residual Disease after allogeneic stem cell transplantation in Acute Myeloid Leukaemia.
- TRIAL ID
NTR3927
- ACRONYM
Prophylactic infusion of CD4 positive donor lymphocytes early after T-cell depleted allogeneic stem cell transplantation in patients with an unrelated donor.
- TRIAL ID
NTR3597
- ACRONYMCD4+ donor lymphocyte infusion
Co-infusion of haematopoietic stem cells from a haplo-identical donor and single unit unrelated cord blood in patients with a high risk of relapse: A Phase l/ll study to assess safety and to investigate the biological mechanism of the anti-tumor response.
- TRIAL ID
NTR3079
- ACRONYMHaploCord
Prevention and treatment of severe GVHD after allogeneic hematopoietic stem cell transplantation, applied as consolidation immunotherapy in patients with hematological malignancies. A prospective randomized phase III trial.
- TRIAL ID
NTR2252
- ACRONYMHOVON 96 GVHD
A phase II study to assess engraftment and engraftment kinetics after double cord blood transplantation with a reduced-intensity conditioning regimen in patients eligible for allogeneic stem cell transplantation lacking a matched unrelated donor.
- TRIAL ID
NTR1573
- ACRONYMEngraftment after double cord blood transplantation.
Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning for High- risk Relapsed or Refractory CLLA prospective multi-centre phase II study
- TRIAL ID
NTR1461
- ACRONYMHOVON 88 CLL
ANTI-CD20 THERAPY FOR THE TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE
- TRIAL ID
NTR1222
- ACRONYMN/A
Bortezomib therapy combined with donor lymphocyte infusion in patients with relapsed Multiple Myeloma following allogeneic stem cell transplantation
- TRIAL ID
NTR949
- ACRONYMDLI-Velcade studie